Zobrazeno 1 - 10
of 329
pro vyhledávání: '"Hyun Hee Lee"'
Publikováno v:
Kidney Research and Clinical Practice, Vol 42, Iss 2, Pp 262-271 (2023)
Background T50 is a novel serum-based marker that assesses the propensity for calcification in serum. A shorter T50 indicates a greater propensity to calcify and has been associated with cardiovascular disease and mortality among patients with chroni
Externí odkaz:
https://doaj.org/article/ff5eaf28893c4880a6ebbac5a068f6b3
Autor:
Ae Jin Kim, Han Ro, Hyunsook Kim, Kwang-Pil Ko, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung
Publikováno v:
Kidney Research and Clinical Practice, Vol 40, Iss 1, Pp 109-119 (2021)
Background The soluble forms of suppression of tumorigenicity-2 (ST2) and galectin-3 have been proposed as novel biomarkers for cardiac fibrosis and heart failure, as well as predictors of cardiovascular events and mortality. However, there are limit
Externí odkaz:
https://doaj.org/article/e676a20b2f7c449f8ebe8e302d30813e
Autor:
Yun Jung Oh, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Young Youl Hyun, Joongyub Lee, Yeong Hoon Kim, Seung Hyeok Han, Dong-Wan Chae, Curie Ahn, Kook-Hwan Oh, Ji Yong Jung
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The benefits and risks of aspirin therapy for patients with chronic kidney disease (CKD) who have a high burden of cardiovascular events (CVE) are controversial. To examine the effects of low-dose aspirin on major clinical outcomes in patien
Externí odkaz:
https://doaj.org/article/6639d5a845fc4c3894accb1a26f1bfe1
Autor:
Taeho Lee, Won Ki Kim, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Objective:Among the various risk factors associated with contrast-induced acute kidney injury (CI-AKI), the importance of osmolality and viscosity is emerging among the characteristics of contrast media (CM) itself. High osmolality CM (HOCM) is depre
Externí odkaz:
https://doaj.org/article/9541a75aa30a4237bafbca043dd9bf60
Autor:
Ji Yong Jung, Han Ro, Jae Hyun Chang, Ae Jin Kim, Hyun Hee Lee, Seung Hyeok Han, Tae-Hyun Yoo, Kyu-Beck Lee, Yeong Hoon Kim, Soo Wan Kim, Sue Kyung Park, Dong-Wan Chae, Kook-Hwan Oh, Curie Ahn, Wookyung Chung
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235077 (2020)
Proteinuria and hyperphosphatemia are risk factors for cardiovascular disease in patients with chronic kidney disease (CKD). Although the interaction between proteinuria and the serum phosphate level is well established, the mechanistic link between
Externí odkaz:
https://doaj.org/article/0eaed073dd59483f831afd10ab229a92
Autor:
Yun Jung Oh, Sun Moon Kim, Byung Chul Shin, Hyun Lee Kim, Jong Hoon Chung, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Chungsik Lee, Ji Yong Jung
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170874 (2017)
Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients with chronic kidney disease (CKD). However, it remains uncertain if the habitual use of RAS inhibitors affects renal progression and outcomes in pre-dialysis pat
Externí odkaz:
https://doaj.org/article/a674e48215fd4933834afd64a08791fa
Autor:
Eun Yeong Cho, Chana Myoung, Hong-Suk Park, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Ji Yong Jung
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170017 (2017)
Chronic kidney disease (CKD) represents a major medical challenge and frequently coexists with cardiovascular disease (CVD), which can be treated by statin trerapy. However, whether statin treatment affects renal progression and outcomes in CKD patie
Externí odkaz:
https://doaj.org/article/08700ee4babd413ba7cea53d85fda6f6
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171044 (2017)
Ovarian cancer (OVC) patients who receive chemotherapy often acquire drug resistance within one year. This can lead to tumor reoccurrence and metastasis, the major causes of mortality. We report a transient increase of a small distinctive CXCR4High/C
Externí odkaz:
https://doaj.org/article/e2e113379eaa46c6bc3fe0378cbe2805
Autor:
Hyun Hee Lee, Yun Jung Hur
Publikováno v:
Korean Journal of Pediatrics, Vol 59, Iss Suppl 1, Pp S29-S31 (2016)
Glucose transport 1 (GLUT-1) deficiency is a rare syndrome caused by mutations in the glucose transporter 1 gene (SLC2A1) and is characterized by early-onset intractable epilepsy, delayed development, and movement disorder. De novo mutations and seve
Externí odkaz:
https://doaj.org/article/7ba825919a6c4774b4e30bd210261b6f
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147255 (2016)
Early detection and accurate differentiation of the cause of AKI may improve the prognosis of the patient. However, to date, there are few reliable biomarkers that can discriminate between pre-renal and intrinsic AKI. In this study, we determined whe
Externí odkaz:
https://doaj.org/article/3ebd476e3b6446bb93c919130539c770